Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria*

Objective:Acute kidney injury affects 5% to 7% of all hospitalized patients with a much higher incidence in the critically ill. The Acute Kidney Injury Network proposed a definition in which serum creatinine rises (>0.3 mg/dL) and/or oliguria (<0.5 mL/kg/hr) for a period of 6 hrs are used to detect acute kidney injury. Accurate urine output measurements as well as serum creatinine values from our database were used to detect patients with acute kidney injury and calculate their corresponding mortality risk and length of stay. Design:Retrospective cohort study. Setting:Seven intensive care units at a large, academic, tertiary medical center. Patients:Adult patients without evidence of end-stage renal disease with more than two creatinine measurements and at least a 6-hr urine output recording who were admitted to the intensive care unit between 2001 and 2007. Interventions:Medical records of all the patients were reviewed. Demographic information, laboratory results, charted data, discharge diagnoses, physiological data, and patient outcomes were extracted from the Multiparameter Intelligent Monitoring in Intensive Care II database using a SQL query. Measurements and Main Results:From 19,677 adult patient records, 14,524 patients met the inclusion criteria. Fifty-seven percent developed acute kidney injury during their intensive care unit stay. Inhospital mortality rates were: 13.9%, 16.4%, 33.8% for acute kidney injury 1, 2, and 3, respectively, compared with only 6.2% in patients without acute kidney injury (p < .0001). After adjusting for multiple covariates, acute kidney injury was associated with increased hospital mortality (odds ratio 1.4 and 1.3 for acute kidney injury 1 and acute kidney injury 2 and 2.5 for acute kidney injury 3; p < .0001). Using multivariate logistic regression, we found that in patients who developed acute kidney injury, urine output alone was a better mortality predictor than creatinine alone or the combination of both. Conclusions:More than 50% of our critically ill patients developed some stage of acute kidney injury resulting in a stagewise increased mortality risk. However, the mortality risk associated with acute kidney injury stages 1 and 2 does not differ significantly. In light of these findings, re-evaluation of the Acute Kidney Injury Network staging criteria should be considered.

[1]  Marlies Ostermann,et al.  Correlation between the AKI classification and outcome , 2008, Critical care.

[2]  S. Bernstein,et al.  Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy , 2008, Annals of Internal Medicine.

[3]  James A Russell,et al.  Early changes in organ function predict eventual survival in severe sepsis* , 2005, Critical care medicine.

[4]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[5]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[6]  H. Rabb,et al.  Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. , 1999, Kidney international.

[7]  K. Polderman,et al.  An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: an international consensus conference in intensive care medicine. , 2010, American journal of respiratory and critical care medicine.

[8]  A. Rule.  Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease , 2007, Current opinion in nephrology and hypertension.

[9]  Prophylaxis of Contrast Material-Induced Nephropathy in Patients in Intensive Care : Acetylcysteine , Theophylline , or Both ? A Randomized Study , 2006 .

[10]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.

[11]  R. Bellomo,et al.  Acute renal failure: time for consensus , 2001, Intensive Care Medicine.

[12]  T. H. Kyaw,et al.  Multiparameter Intelligent Monitoring in Intensive Care II: A public-access intensive care unit database* , 2011, Critical care medicine.

[13]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[14]  R. Bellomo,et al.  Acid–base status of critically ill patients with acute renal failure: analysis based on Stewart–Figge methodology , 2003, Critical care.

[15]  P. Trerotoli,et al.  A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients* , 2006, Critical care medicine.

[16]  C. Sprung,et al.  Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score , 2000, Intensive Care Medicine.

[17]  L. Bachmann,et al.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. , 2004, Journal of the American Society of Nephrology : JASN.

[18]  Joseph V Bonventre,et al.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.

[19]  P. Metnitz,et al.  Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database , 2009, Intensive Care Medicine.

[20]  K E Hammermeister,et al.  Independent association between acute renal failure and mortality following cardiac surgery. , 1998, The American journal of medicine.

[21]  J. Brinker,et al.  A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.

[22]  R. Bellomo,et al.  Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebo-controlled pilot trial* , 2005, Critical care medicine.

[23]  W. Bautz,et al.  Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. , 2009, Radiology.

[24]  R. Bellomo,et al.  A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  John A Kellum,et al.  Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  M. Saeed,et al.  Multiparameter Intelligent Monitoring in Intensive Care Ii (Mimic-Ii): A Public-Access Intensive Care Unit Database , 2011 .

[27]  G. Bernard,et al.  Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome , 2002, Critical care medicine.

[28]  R. Bellomo,et al.  Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.

[29]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.